Opioid and Cannabinoid Interactions

• Status: Recruiting
• Trial end date: 2023-12-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will examine the effects of doses of marijuana/placebo and doses of opioid/placebo, alone and in combination. The primary outcomes are related to pharmacodynamic measures (subjective ratings of drug liking and other abuse-related effects; physiological outcomes) to determine the interaction effects of these compounds.

• Phase: Phase 1
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Shanna Babalonis, PhD
• Treatments: Analgesics, Opioid

Criteria

Inclusion Criteria:

• Healthy adults ages 18-50

• Current non-medical use of opioids and marijuana

Exclusion Criteria:

• Physical dependence on opioids, alcohol benzodiazepines/sedative/hypnotics

• Seeking treatment for drug use

• Significant medical problems